Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
US7745464B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Inventors
Key dates
| Filing date | Dec 15, 2006 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | May 24, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.